Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Database Funding Needed To Sell Investigators On Combat Meth Enforcement

This article was originally published in The Tan Sheet

Executive Summary

Adequate funding for electronic databases to track retail sales of pseudoephedrine products may be needed to convince law enforcement officials in states besieged by manufacturing of methamphetamine that current PSE sales restrictions are sufficient

You may also be interested in...



Industry Goes On Offensive Against Prescription Pseudoephedrine Trend

Drug firms hope to dissuade states from moving drugs that contain methamphetamine precursors to prescription status by funding electronic systems to track nonprescription sales of the products

Industry Goes On Offensive Against Prescription Pseudoephedrine Trend

Drug firms hope to dissuade states from moving drugs that contain methamphetamine precursors to prescription status by funding electronic systems to track nonprescription sales of the products

Industry Goes On Offensive Against Prescription Pseudoephedrine Trend

Drug firms hope to dissuade states from moving drugs that contain methamphetamine precursors to prescription status by funding electronic systems to track nonprescription sales of the products

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS102021

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel